Human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) Western blot indeterminate results
are a problem for blood banks in endemic areas. To determine the prevalence of HTLV-1/2 …

Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …

Human T lymphocytotropic virus HTLV is a virus from retroviridae family, and more than 20
million people are infected with this virus worldwide. It can cause leukemia/lymphoma in …

In 2002, human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 seroprevalence was
0.16%(8/4,900) in blood donors from Dakar, Senegal. Most of the positive donors originated …

Introduction: Transmission of human T-lymphotropic viruses (HTLV) occurs from mother to
child, by sexual contact and blood transfusion. Presently, in most centres in Nigeria, there is …

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood
donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe …

Background The human T-lymphotropic virus type 1 (HTLV-1) which is associated with the
diseases of adult T-cell leukemia/lymphoma, HTLV-1 associated myelopathy/tropical spastic …

Background-HTLV is a lymphotropic virus which can contribute to carcinogenesis in adult T-
cell leukemia. The prevalence of this virus in Northeastern Iran has led us to investigate …

Background: HTLV type I/II is a blood borne infection that can be transmitted via blood
transfusion. Objective: To determine the seroprevalence of human T–lymphotropic virus …

Background and objectives Donated blood is not currently screened for human T‐cell
lymphotropic virus (HTLV) in South Africa. Several small studies have detected HTLV‐1 in …